ArticleFrontiers in immunology2025

The C/EBPβ antagonist peptide lucicebtide (ST101) induces macrophage polarization toward a pro-inflammatory phenotype and enhances anti-tumor immune responses.

Claudio Scuoppo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.